Research · Publications

Publications & presentations.

Peer-reviewed work and conference presentations, with an emphasis on rheumatic disease in pregnancy.

Selected publications

  1. Tharmarajah S, Hussain S, Guilcher SJT, McCarthy LM, Mahendira D, Berger H, Tadrous M. Real-world trends in prenatal antirheumatic drug utilization in Ontario, Canada: a cross-sectional time-series analysis. Arthritis Care & Research. 2026. View article
  2. Tharmarajah S, Abideen Z, Hussain S, Guilcher SJT, McCarthy LM, Mahendira D, Berger H, Tadrous M. Real-world trends in rheumatic disease rates among pregnancies in Ontario, Canada: a repeated cross-sectional study. PLoS One. 2025;20(9):e0332374. View article
  3. Tharmarajah S, Santhireswaran A, Ameeriar Y, McCarthy LM, Mahendira D, Berger H, Tadrous M, Guilcher SJT. Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: a scoping review. PLoS One. 2025;20(3):e0319703. View article
  4. Tharmarajah S, Guilcher SJT, Santhireswaran A, McCarthy LM, Mahendira D, Berger H, Tadrous M. Use of administrative claims data in observational studies of antirheumatic medication effects on pregnancy outcomes: a scoping review protocol. JBI Evidence Synthesis. 2024;22(1):106-115. View article
  5. Brosseau L, et al. (incl. Mahendira D). The Ottawa Panel guidelines on programmes involving therapeutic exercise for the management of hand osteoarthritis. Clinical Rehabilitation. 2018;32(11):1449-1471. View article
  6. Shamis J, Widdifield J, Batthish M, Mahendira D, Jamal S, Cividino A, Lethebe BC, Barber CE. Factors influencing rheumatology residents' decision on future practice location. Canadian Medical Education Journal. 2021;12(2):e63-e68. View article
  7. Arya S, Mahendira D, Pattani R. Bilateral necrotizing scleritis: a deeper look at a vision-threatening illness. Journal of Clinical Rheumatology. 2020;26(4):e75-e76. View article
See all publications on PubMed

Publication records via PubMed (U.S. National Library of Medicine). Links resolve to each article's publisher page.

Other meetings, symposia, and workshop presentations

Selected invited lectures and conference presentations. Where a trainee presented shared work, Dr. Mahendira is a co-author or senior author.

Invited lectures and presentations

  1. Inflammation and pregnancy. GLIDE Immunology 2026, Toronto. Invited speaker and panellist. 2026.
  2. Rheumatic diseases and pregnancy: navigating a complex landscape. University of Toronto Division of Rheumatology City-Wide Rounds, Toronto. Invited speaker and moderator. 2026.
  3. Approach to inflammatory arthritis, radiology, and serology. RheumAcademy national preparatory course for allied health professionals. Invited speaker. 2026.
  4. Inflammatory arthritis and pregnancy. Accredited CME activity, virtual. Invited speaker. 2026.
  5. Managing inflammation in pregnancy: dermatology, gastroenterology, obstetrics, and rheumatology perspectives. Multidisciplinary Care for IBD webinar, virtual. Invited speaker. 2024.
  6. Rheumatic diseases and pregnancy. McMaster University Division of Rheumatology Grand Rounds, Hamilton. Invited presenter. 2024.
  7. 2022 update on rheumatic diseases and pregnancy. AHPA National Speaker Series, virtual. Invited lecturer. 2022.
  8. Reproduction and rheumatic disease. Canadian Rheumatology Association Annual Scientific Meeting (with C. Laskin). Invited lecturer. 2021.

Selected abstracts and conference presentations

  1. Risk of adverse pregnancy outcomes in individuals with rheumatic diseases using prenatal antirheumatic drugs: a population-based cohort study. American College of Rheumatology Convergence 2025, Chicago. Oral presentation. 2025.
  2. Risk of adverse pregnancy outcomes in individuals with rheumatic diseases using prenatal antirheumatic drugs: a population-based cohort study. ISPE Annual Meeting, Washington, DC. Oral presentation. 2025.
  3. Male perspectives on anti-rheumatic drug use during peri-conception. 13th International Conference on Reproduction, Pregnancy and Rheumatic Diseases, Vienna. 2025.
  4. From pre-conception to post-partum: an interdisciplinary guide to caring for women with spondyloarthritis. Workshop. Canadian Rheumatology Association Annual Scientific Meeting, Halifax. 2026.
  5. Use of administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: a scoping review. ISPE Annual Meeting, Berlin. 2024.
  6. Disease-modifying antirheumatic drugs and biologic therapy use during pregnancy: a single-centre mixed-methods study. The Lancet Summit: sex and gender in rheumatology, London. 2022.
  7. Disease-modifying antirheumatic drugs and biologic therapy use during pregnancy. Rheumatology and Pregnancy Conference, Milan. 2020.

Compiled from Dr. Mahendira's curriculum vitae.